Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Currents in Pharmacy Teaching & Learning|December 1, 2019
Self-perceived knowledge and confidence regarding infectious diseases of advanced pharmacy practice experience studentsMelissa A Johnson, Bruce M Jones, Emily L Heil, et al.
Open Forum Infectious Diseases|December 27, 2023
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue InfectionsEmily L Heil, Harpreet Kaur, Anthony Atalla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2018
The Cost of Self-Reported Penicillin Allergy: A Systematic ReviewT Joseph Mattingly, Anne Fulton, Rachel A Lumish, et al.
Open Forum Infectious Diseases|October 6, 2016
Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing ServiceEmily L Heil, Jacqueline T Bork, Sarah A Schmalzle, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2018
An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two CitiesJason M Pogue, Emily L Heil, Paul Lephart, et al.
Pharmacotherapy|April 5, 2020
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile InfectionAna D Vega, Emily L Heil, Alison L Blackman, et al.
Jac-Antimicrobial Resistance|May 16, 2023
Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatientsJonathan D Baghdadi, Katherine E Goodman, Laurence S Magder, et al.
International Journal of STD & AIDS|August 18, 2022
Pap smear outcomes in elderly women living with HIV and HIV-negative matched controlsKylie L Klein, Abby R Goron, Gregory H Taylor, et al.
Mutagenesis|January 9, 2026
Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humansPage B McKinzie, Rutu R Valapil, Emily L Heil, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft functionSari R Freedman, Bharath R Ravichandran, Brian M Masters, et al.
Pageof 12